Bitran Jd
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 5
- Oncology top 10%
- Lung Cancer Research Studies 9
- Cancer Treatment and Pharmacology 7
- Cancer Cells and Metastasis 4
- Colorectal Cancer Treatments and Studies 3
- Transplantation top 10%
- Genetics top 10%
-
- Lung Cancer Treatments and Mutations 13
-
- Neuroendocrine Tumor Research Advances 4
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Cited by
- HematologyOncologyTransplantation
- Partner nations
- United States
In The Last Decade
Bitran Jd
33 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Hematology 596
- Oncology 431
- Transplantation 40
- Genetics 135
- Public Health, Environmental and Occupational Health 247
Countries citing papers authored by Bitran Jd
This map shows the geographic impact of Bitran Jd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bitran Jd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bitran Jd more than expected).
Fields of papers citing papers by Bitran Jd
This network shows the impact of papers produced by Bitran Jd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bitran Jd. The network helps show where Bitran Jd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bitran Jd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 16 | |
| 2 | 1998 | 26 | |
| 3 | Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. | 1996 | 55 |
| 4 | 1996 | 2 | |
| 5 | A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells. | 1996 | 5 |
| 6 | Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer. | 1995 | 25 |
| 7 | 1992 | 3 | |
| 8 | Chemotherapy for stage IV non-small cell lung cancer. | 1990 | 20 |
| 9 | A phase I-II study of high-dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. | 1990 | 10 |
| 10 | High-dose combination chemotherapy with thiotepa and autologous hematopoietic stem cell reinfusion in the treatment of patients with relapsed refractory lymphomas. | 1990 | 41 |
| 11 | Patients at increased risk for late engraftment after transplantation: a novel method for their identification. | 1990 | 9 |
| 12 | 1987 | 194 | |
| 13 | 1987 | 166 | |
| 14 | Treatment of metastatic colorectal carcinoma with cisplatin and 5-FU. | 1985 | 10 |
| 15 | Warfarin, etoposide, and vindesine interactions. | 1984 | 5 |
| 16 | 1984 | 7 | |
| 17 | Melphalan, vincristine, and 5-FU in advanced colonic carcinoma: results of a pilot study. | 1981 | 1 |
| 18 | Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM). | 1980 | 61 |
| 19 | Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. | 1978 | 13 |
| 20 | Megaloblastic anemia during pregnancy. | 1977 | 2 |
About Bitran Jd
Bitran Jd is a scholar working on Oncology, Transplantation, Hematology, Pulmonary and Respiratory Medicine and Hepatology, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (9 papers), Cancer Treatment and Pharmacology (7 papers), Hematopoietic Stem Cell Transplantation (5 papers), Neuroendocrine Tumor Research Advances (4 papers), Cancer Cells and Metastasis (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Hematology (596 citations), Oncology (431 citations), Transplantation (40 citations), Genetics (135 citations) and Public Health, Environmental and Occupational Health (247 citations). Bitran Jd has collaborated with scholars based in United States. Frequent co-authors include P. C. Hoffman, C Skosey, S Purl, JW Vardiman, MJ Ratain, MM Le Beau, Richard A. Larson, James L. Wade, HM Golomb and Rosemarie Mick. Their work appears in journals such as Lung Cancer, Blood, CA A Cancer Journal for Clinicians, Journal of Clinical Oncology and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.